Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Associations of the Expression Levels and Risk Variants of CDKN2B-AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer.

Journal of cellular and molecular medicine - 1 Dec 2024

Tung Min-Che, Lin Chia-Yen, Wen Yu-Ching, Chang Lun-Ching, Yang Shun-Fa, Chien Ming-Hsien

Abstract excerpt

Genetic variants of deregulated long noncoding RNAs (lncRNAs) have been implicated in tumorigenesis, cancer progression and cancer recurrence. Single-nucleotide polymorphisms (SNPs) of the lncRNA cyclin-dependent kinase inhibitor 2B antisense RNA 1 (CDKN2B-AS1) have been associated with the risk and progression of various cancers; however, their role in prostate cancer (PCa) remains underexplored. In this...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Gene Expression Regulation, Neoplastic

Share to Neoplasm Grading

Share to Prostatic Neoplasms

Share to Risk Factors

Share to RNA, Long Noncoding

Source

Open in PubMed Open full text

Identifiers

PMID: 39632396
DOI: 10.1111/jcmm.70264
PMCID: PMC11617473

Genes

CDKN2B

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of the Expression Levels and Risk Variants of CDKN2B-AS1 Long Noncoding RNA With the Susceptibility and Progression of Prostate Cancer.PMID 39632396Read ↗

Disease-Associated Risk Variants and Expression Levels of the lncRNA, CDKN2B-AS1, Are Associated With the Progression of HCC.Semantic proximity Read ↗

A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.Semantic proximity Read ↗

Modulation of long noncoding RNAs by risk SNPs underlying genetic predispositions to prostate cancer.Semantic proximity Read ↗

Association between lncrna PCGEM1 polymorphisms and prostate cancer risk.Semantic proximity Read ↗

Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancerSemantic proximity Read ↗

Overexpression of AR‐regulated lncRNA TMPO‐AS1 correlates with tumor progression and poor prognosis in prostate cancerSemantic proximity Read ↗

Long Non-Coding RNAs at the Chromosomal Risk Loci Identified by Prostate and Breast Cancer GWAS.Semantic proximity Read ↗

The use of exome genotyping to predict pathological Gleason score upgrade after radical prostatectomy in low-risk prostate cancer patients.Semantic proximity Read ↗

Association of cyclin-dependent kinase inhibitor 2B antisense RNA 1 gene expression and rs2383207 variant with breast cancer risk and survival.Semantic proximity Read ↗

PRNCR1: a long non-coding RNA with a pivotal oncogenic role in cancer.Semantic proximity Read ↗

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.Semantic proximity Read ↗

PTBP1 Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.